Medivir AB is a Swedish pharmaceutical company that develops medicines for infectious diseases and cancer. Its work centres on antiviral treatments, including a topical cream for cold sores caused by the herpes simplex virus, and on research into cancer therapies. The company carries out drug discovery and clinical development and is based in Stockholm, Sweden, where it manages its research programmes and partnerships with other pharmaceutical firms.
Medivir AB trades under the code MVIR on the Nasdaq Stockholm in Sweden, with its price quoted in Swedish kronor (SEK). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #522 of 912 on the Nasdaq Stockholm · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Sweden yet.
TrendWeak
47/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-6.6%
From 52-week high-43.5%
MomentumFair
54/100
Typical recent returns for this exchange.
See the numbers →
3-month return-12.8%
6-month return-19.3%
12-month, skipping last month198.7%
Stability (higher is calmer)Weak
24/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)122.1%
Worst drawdown, 1 year (smaller is calmer)-48.7%
LiquidityFair
70/100
Moderate trading activity.
See the numbers →
Avg daily value traded2.81M SEK
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Sweden when fundamentals data for this market is added. All Sweden stocks.
52-wk range 0.340 – 2.885Daily closes, split-adjusted
Signals
50-day average1.701
200-day average1.677
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.070
Technical summary
Daily
Bearish
5 bullish · 2 neutral · 9 bearish
Weekly
Strongly bearish
1 bullish · 1 neutral · 10 bearish
Monthly
Bearish
2 bullish · 1 neutral · 5 bearish
Moving averages (daily)
SMA 10
1.49
Bullish
EMA 10
1.51
Bullish
SMA 20
1.52
Bullish
EMA 20
1.54
Bullish
SMA 50
1.70
Bearish
EMA 50
1.63
Bearish
SMA 100
1.72
Bearish
EMA 100
1.68
Bearish
SMA 200
1.68
Bearish
EMA 200
1.66
Bearish
Oscillators (daily)
RSI (14)
49.86
Neutral
MACD (12, 26)
-0.05
Bearish
Momentum (12)
4.82
Bullish
Stochastic %K (14)
86.21
Bearish
Williams %R (14)
-13.79
Bearish
CCI (20)
47.51
Neutral
Pivot points (classic, last session)
S3
1.50
S2
1.53
S1
1.55
Pivot
1.57
R1
1.59
R2
1.61
R3
1.63
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in SEK. Educational only, not financial advice.
